Newbridge Financial Services Group, Inc. Cue Biopharma, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $262 Million
- Q2 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 3,000 shares of CUE stock, worth $1,770. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,000
Previous 3,000
-0.0%
Holding current value
$1,770
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CUE
# of Institutions
77Shares Held
13.8MCall Options Held
56.1KPut Options Held
11.1K-
Bleichroeder LP New York, NY2.86MShares$1.69 Million1.28% of portfolio
-
Slate Path Capital LP New York, NY2.4MShares$1.42 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.03MShares$1.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$446,4740.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny494KShares$291,4520.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $20.9M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...